XTL Biopharmaceuticals Ltd. (XTLB) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
XTLB Historical Performance
Short-Term Returns
XTLB Stock Price Trajectory (2011–2026)
As of May 8, 2026, XTL Biopharmaceuticals Ltd. (XTLB) trades at $2.67, representing a -50.9% return over the past year. The stock has delivered a -80.4% total return over five years (-27.8% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $2,400.00 on September 1, 2005. From this peak, XTLB has corrected -99.9%, currently trading 32% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers NRXP (+55.3% 1Y), SIGA (-9.9% 1Y), and BFRI (+62.5% 1Y), XTLB has underperformed the peer group average. Compare XTLB vs NRXP →
XTLB Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 3.06 | 3.18 | 2.60 | 2.67 | 102K | -17.85% |
| 2026-05-06 | 3.63 | 3.64 | 3.00 | 3.25 | 128K | -11.20% |
| 2026-05-05 | 3.53 | 4.01 | 3.51 | 3.66 | 163K | -4.19% |
| 2026-05-04 | 3.52 | 4.00 | 3.46 | 3.82 | 340K | +4.66% |
| 2026-05-01 | 3.93 | 4.00 | 3.49 | 3.65 | 1.74M | -6.41% |
| 2026-04-30 | 3.56 | 3.95 | 3.11 | 3.90 | 1.56M | +9.55% |
| 2026-04-29 | 3.80 | 4.87 | 3.22 | 3.56 | 113.44M | +54.78% |
| 2026-04-28 | 2.32 | 2.32 | 2.28 | 2.30 | 11K | -3.77% |
| 2026-04-27 | 2.43 | 2.64 | 2.39 | 2.39 | 9K | -1.65% |
| 2026-04-24 | 2.39 | 2.45 | 2.39 | 2.43 | 4K | -0.41% |
| 2026-04-23 | 2.49 | 2.55 | 2.42 | 2.44 | 8K | -2.79% |
| 2026-04-22 | 2.59 | 2.62 | 2.51 | 2.51 | 3K | +1.62% |
| 2026-04-21 | 2.44 | 2.52 | 2.43 | 2.47 | 4K | +1.65% |
| 2026-04-20 | 2.55 | 2.58 | 2.40 | 2.43 | 8K | -0.82% |
| 2026-04-17 | 2.60 | 2.60 | 2.37 | 2.45 | 5K | -1.21% |
| 2026-04-16 | 2.47 | 2.48 | 2.35 | 2.48 | 9K | +4.20% |
| 2026-04-15 | 2.48 | 2.48 | 2.35 | 2.38 | 6K | -2.46% |
| 2026-04-14 | 2.40 | 2.50 | 2.37 | 2.44 | 8K | +1.67% |
| 2026-04-13 | 2.38 | 2.45 | 2.34 | 2.40 | 8K | +1.27% |
| 2026-04-10 | 2.59 | 2.59 | 2.35 | 2.37 | 2K | -4.44% |
| 2026-04-09 | 2.38 | 2.52 | 2.38 | 2.48 | 18K | +5.98% |
| 2026-04-08 | 2.39 | 2.45 | 2.34 | 2.34 | 10K | -1.68% |
| 2026-04-07 | 2.49 | 2.50 | 2.38 | 2.38 | 4K | -4.42% |
| 2026-04-06 | 2.36 | 2.59 | 2.36 | 2.49 | 2K | +2.47% |
| 2026-04-02 | 2.47 | 2.47 | 2.30 | 2.43 | 12K | -0.82% |
| 2026-04-01 | 2.34 | 2.46 | 2.33 | 2.45 | 7K | +1.66% |
| 2026-03-31 | 2.51 | 2.51 | 2.41 | 2.41 | 9K | -7.66% |
| 2026-03-30 | 2.52 | 2.61 | 2.46 | 2.61 | 3K | +3.98% |
| 2026-03-27 | 2.55 | 2.66 | 2.45 | 2.51 | 7K | -4.56% |
| 2026-03-26 | 2.65 | 2.88 | 2.62 | 2.63 | 18K | -2.95% |
See XTLB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XTLB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XTLB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXTLB — Frequently Asked Questions
Quick answers to the most common questions about buying XTLB stock.
How has XTLB stock performed recently?
XTLB declined -50.9% over the past year, below its 5-year annualized CAGR of -27.8%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is XTLB's all-time high price?
XTL Biopharmaceuticals Ltd. reached $2400.00 on 2005-09-01. The 52-week high is $10.28. Current 1-year return of -50.9% places the stock further from historical peaks.
Where can I download XTLB historical price data?
This page provides XTLB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.